Beyond the Common Cold: Managing Allergic Rhinitis With Modern Antihistamines

Allergic rhinitis is a chronic condition that can usually be managed effectively
An ENT specialist explains why the condition should not be dismissed as a passing inconvenience.
Mark

Why do so many people with allergic rhinitis go undiagnosed if it affects more than 30 percent of the population?

Mimi

Because it mimics a cold so closely that people assume it will pass. They don't see a doctor. They don't get tested. And by the time they realize it's chronic, they've already normalized living with it.

Mark

So it's not that the condition is rare—it's that people don't recognize it as a distinct problem?

Mimi

Exactly. A cold has a clear endpoint. Allergic rhinitis doesn't. It lingers, it returns, and people just accept the sneezing and congestion as part of life. The study showed 85 percent of young adults with the condition had never been diagnosed.

Mark

What changes when someone does get diagnosed and treated?

Mimi

Everything, potentially. Sleep improves. Concentration comes back. Work and school performance stabilize. But the real shift is moving from reactive treatment—taking medication when symptoms flare—to preventive treatment. Taking it regularly, before symptoms start.

Mark

And the newer antihistamines are different from what people might remember taking years ago?

Mimi

Completely different. Older antihistamines made you drowsy because they crossed into the brain. Newer ones like fexofenadine don't. You get symptom relief without the fog. That matters for someone who drives or studies.

Mark

Is there a reason dust mites are such a problem in Singapore specifically?

Mimi

The climate. No distinct pollen seasons means no seasonal relief. Dust mites thrive year-round in the heat and humidity. They're not going away, so the allergen exposure is constant.

Mark

What's the practical first step for someone who suspects they have this?

Mimi

Talk to a doctor. Get diagnosed. Then combine two things: environmental control—washing bedding at 60 degrees regularly—and medication. Neither alone is enough. Together, they work.

  • A condition affecting nearly a third of Singaporeans goes largely unnamed — 85 percent of those with allergic rhinitis have never received a diagnosis, leaving most to mistake a chronic immune disorder for a recurring cold.
  • The consequences are not trivial: disrupted sleep, eroded concentration, and diminished performance at work and school accumulate silently in people who believe they are simply prone to sniffles.
  • Older antihistamines offered relief at a cost — drowsiness that made them incompatible with driving, operating machinery, or sitting an exam — creating a quiet barrier between treatment and daily function.
  • Second-generation antihistamines like fexofenadine now provide symptom control within the hour while leaving mental clarity intact, reshaping who can realistically seek and sustain treatment.
  • The emerging standard of care asks patients to stop waiting for flare-ups and instead adopt preventive, ongoing treatment — a conceptual shift that transforms allergic rhinitis from something endured into something managed.

Across Singapore, more than three in ten people live with a condition that mimics the common cold but never truly resolves — allergic rhinitis, a chronic immune response to the invisible allergens woven into everyday tropical life. Despite its prevalence, the vast majority of those affected have never been diagnosed, quietly absorbing disrupted sleep, fractured focus, and diminished wellbeing as the ordinary cost of existence. Modern medicine offers a quieter revolution: second-generation antihistamines that relieve symptoms without stealing alertness, and a shift in philosophy from enduring illness to managing it with intention.

Most Singaporeans who spend a week sneezing and congested assume they have a cold and wait for it to pass. But for more than three in ten, the symptoms never fully resolve — returning year-round in a humid climate where house dust mites replace seasonal pollen as the constant trigger. What they are living with is allergic rhinitis: the immune system's chronic overreaction to harmless environmental substances, releasing histamine and producing sneezing, congestion, and itching that can persist indefinitely.

The scale of underdiagnosis is striking. A 2024 study found that while 68 percent of young Singaporeans with the condition had moderate-to-severe disease, 85 percent had never been diagnosed and 73 percent were receiving no treatment at all. The condition quietly erodes sleep, concentration, and productivity — yet most people absorb it as a minor inconvenience rather than a manageable medical condition. ENT specialist Dr Soma Subramaniam is direct: allergic rhinitis cannot be cured, but it can be controlled.

Treatment begins with the environment — washing bedding at 60 degrees Celsius reduces dust mite exposure — but medication remains essential. Older antihistamines, which cross the blood-brain barrier, frequently cause drowsiness that makes them unsuitable for anyone who needs to stay alert. Second-generation options like fexofenadine work differently, offering relief within 45 minutes to an hour with minimal sedation — a meaningful distinction for drivers, machine operators, and students.

The deeper shift is philosophical. Rather than reaching for medication only when symptoms flare, Dr Soma advocates preventive treatment for those with persistent disease — regular medication combined with allergen avoidance, sustained over time. It is a small reframing with significant consequences: from enduring a nuisance to actively reclaiming quality of life.

Most people who spend a week sneezing, congested, and rubbing their eyes assume they've caught a cold. They wait it out, drink water, and expect it to pass. But for more than three in ten Singaporeans, that scratchy throat and runny nose never quite goes away. It returns, season after season, or in this climate, year-round. What they're experiencing is allergic rhinitis—a condition so common it's nearly invisible, yet so often misunderstood that the majority of people living with it have never been properly diagnosed.

The confusion is understandable. Allergic rhinitis and a cold share the same surface symptoms: sneezing, nasal congestion, itchy eyes. But they are fundamentally different. A cold is a viral infection that typically resolves within one to two weeks, often accompanied by fever, body aches, and fatigue. Allergic rhinitis is not contagious. It is a chronic inflammatory condition—the immune system's overreaction to harmless substances in the environment. In Singapore's warm, humid climate, where pollen seasons don't exist in the traditional sense, house dust mites are the year-round culprit. When someone with allergic rhinitis inhales dust mite allergens, their immune system misidentifies them as a threat and releases histamine, the chemical messenger that triggers sneezing, congestion, and itching.

The scale of the problem is striking. A 2024 study of young adults in Singapore found that while 68 percent of those with allergic rhinitis had moderate-to-severe disease, 85 percent had never been diagnosed and 73 percent were not receiving any treatment. The condition disrupts sleep, fractures concentration, and ripples through school performance, work productivity, and mood. Yet many people treat it as a minor inconvenience, something to endure rather than address. Dr Soma Subramaniam, an ear, nose and throat specialist and medical director of ENT Plus Specialist Centre, pushes back against this resignation. "Allergic rhinitis is a chronic inflammatory condition that can usually be managed effectively with appropriate treatment to minimise symptoms in the long term," he says. The key word is managed—not cured, but controlled.

The first line of defense is environmental. Washing bedsheets and pillowcases regularly at 60 degrees Celsius can meaningfully reduce dust mite exposure. But allergen avoidance alone is rarely enough. Medication matters, and the approach has evolved. Antihistamines work by blocking histamine receptors, preventing the chemical from triggering symptoms. Older, first-generation antihistamines, developed decades ago, cross the blood-brain barrier and frequently cause drowsiness—a side effect that makes them unsuitable for anyone who needs to stay alert. Second-generation antihistamines, by contrast, are less likely to cross that barrier, offering symptom relief with minimal sedation. Fexofenadine, a commonly prescribed second-generation option, can provide relief within 45 minutes to an hour.

Choosing the right treatment depends on which symptoms dominate. Antihistamines excel at controlling sneezing, itching, and runny nose. If nasal blockage is the primary problem, a decongestant spray or a combination medication may work better. But decongestants come with caution: they are not suitable for everyone and should be used only for short-term relief, not as daily maintenance. Pseudoephedrine-containing products should not be used continuously for more than a week. For people whose work or studies demand alertness—drivers, machine operators, students in exam season—the choice of antihistamine matters. Fexofenadine offers an option that doesn't compromise focus.

The larger shift is conceptual. Rather than waiting for symptoms to flare and then reaching for medication, Dr Soma advocates preventive treatment for those with severe persistent allergic rhinitis. Regular, ongoing medication combined with allergen avoidance measures produces better long-term outcomes than the reactive approach of treating each outbreak as it arrives. It's a small reframing, but it changes everything: from managing a nuisance to reclaiming quality of life.

Allergic rhinitis is a chronic inflammatory condition that can usually be managed effectively with appropriate treatment to minimise symptoms in the long term
— Dr Soma Subramaniam, ENT specialist and medical director of ENT Plus Specialist Centre
For individuals with severe persistent allergic rhinitis, regular preventive treatment may be more effective than treating flare-ups after they occur and could lead to a better quality of life
— Dr Soma Subramaniam
Vuoi la storia completa? Leggi l'originale su CNA ↗
Contattaci Domande frequenti